Mitotically Active Leiomyoma of the Uterus in a Postmenopausal Breast Cancer Patient Receiving Tamoxifen
Objective: Mitotically active leiomyoma of the uterus complicated with postmenopausal vaginal bleeding has never been reported in Taiwan. Here, we present a case of mitotically active leiomyoma of the uterus complicated with postmenopausal vaginal bleeding in a breast cancer patient who had been rec...
Main Authors: | I-Feng Liu, Yu-Shan Yen, Ya-Min Cheng, Cheng-Yang Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-06-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455909602187 |
Similar Items
-
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
by: Karin Beelen, et al.
Published: (2018-07-01) -
Primary ovarian leiomyoma associated with multiple uterine leiomyomas
by: Yoshihiro Kitamura, et al.
Published: (2021-01-01) -
Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
by: I O Mamikonyan, et al.
Published: (2015-02-01) -
Comparative study on the efficacy of tamoxifen and letrozole in the adjuvant hormonal therapy of postmenopausal breast cancer
by: Mei Yang
Published: (2016-05-01) -
Leiomyoma of the breast: a case report
by: Afonso Celso Pinto Nazário, et al.